Fanconi anemia complementation group A
Information
- Disease name
- Fanconi anemia complementation group A
- Disease ID
- DOID:0111095
- Description
- "A Fanconi anemia that has_material_basis_in homozygous or compound heterozygous mutation in the FANCA gene on chromosome 16q24." [url:https\://www.ncbi.nlm.nih.gov/pubmed/10094191, url:https\://www.ncbi.nlm.nih.gov/pubmed/9371798]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04069533 | Active, not recruiting | Phase 2 | Lentiviral-mediated Gene Therapy for Pediatric Patients With Fanconi Anemia Subtype A | November 28, 2019 | February 2025 |
| NCT04248439 | Active, not recruiting | Phase 2 | Gene Therapy for Fanconi Anemia, Complementation Group A | July 15, 2020 | May 2026 |
| NCT04437771 | Enrolling by invitation | Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene Therapy | June 1, 2020 | January 30, 2035 | |
| NCT03814408 | Unknown status | Phase 1 | A Clinical Trial to Evaluate the Safety of RP-L102 in Pediatric Subjects With Fanconi Anemia Subtype A | January 11, 2019 | March 2022 |
- Disase is a (Disease Ontology)
- DOID:13636
- Cross Reference ID (Disease Ontology)
- MIM:227650
- Exact Synonym (Disease Ontology)
- FANCA